Keyphrases
Bone Health
100%
Randomized Clinical Trial
100%
GLP-1 Receptor Agonist
100%
Agonist Treatment
100%
Liraglutide
100%
Combination Treatment
100%
Bone Mineral Density
50%
Weight Loss
50%
Placebo Groups
37%
Exercise Group
37%
Glucagon-like peptide-1 Receptor (GLP-1R)
25%
Low-calorie Diet
25%
Weight Loss Strategies
25%
Clinically Significant
25%
Lumbar Spine
25%
Obesity Body Mass Index
12%
Exercise Intensity
12%
EudraCT
12%
Moderate-to-vigorous Intensity
12%
Receptor Agonist
12%
University of Copenhagen
12%
A1 Receptor
12%
Distal Forearm
12%
Bone Loss
12%
Change in Weight
12%
Dual-energy X-ray Absorptiometry
12%
Spine
12%
Denmark
12%
Intention-to-treat
12%
Effective Weight
12%
Forearm
12%
Without Diabetes
12%
Placebo
12%
Dietary Weight Loss
12%
Exercise Program
12%
Bone Mass
12%
Glucagon-like
12%
Hip-spine
12%
End of Treatment
12%
Medicine and Dentistry
Glucagon-Like Peptide-1 Agonist
100%
Liraglutide
100%
Randomized Clinical Trial
100%
Bone Density
50%
Hip
50%
Placebo
50%
Lumbar Spine
25%
Low Calorie Diet
25%
Body Mass Index
25%
Absorptiometry
12%
Osteolysis
12%
Glucagon Like Peptide 1
12%
Diabetes
12%
Intention-to-Treat Analysis
12%
Exercise Intensity
12%
Bone Mass
12%
Immunology and Microbiology
Agonist
100%
Hip
100%
Bone Density
100%
Lumbar Spine
50%
Calorie
50%
Spine
50%
Osteolysis
25%
Bone Mass
25%
Exercise Intensity
25%
Body Mass
25%
